Loading...
Rabbit syndrome: update on aetiology and management for pharmacists, psychiatrists and dentists
Reyad, Ayman Antoun Girgis, Eriny Mishriky, Raafat
Reyad, Ayman Antoun
Girgis, Eriny
Mishriky, Raafat
Editors
Other contributors
Affiliation
Epub Date
Issue Date
2019-03-28
Submitted date
Alternative
Abstract
Rabbit syndrome (RS) is an involuntary movement disorder, characterized by fast and fine movements of oral and masticatory muscles along the mouth vertical axis in the absence of tongue involvement. RS prevalence varies between 2.3% to 4.4% and could result from the administration of antipsychotics and antidepressants. In case of second generation antipsychotics, there is a reduced risk of RS compared with first generation antipsychotics with mainly isolated literature case reports especially with the use of risperidone as antipsychotic. RS affects only the buccal region, with the possible involvement of the basal ganglia, in particular the substantia nigra. The management of RS include reduction or change of the psychotropic treatment and use of anticholinergic medications such as trihexyphenidyl. Although RS is rare and easily treatable, it is essential that dentists and psychiatrists could distinguish this syndrome from other movement disorders such as tardive dyskinesia.
Citation
Reyad, A. A., Girgis, E. and Mishriky, R. (2019) Rabbit syndrome: update on aetiology and management for pharmacists, psychiatrists and dentists, International Journal of Current Medical And Pharmaceutical Research, 5(3), pp. 4103-4105.
Publisher
Research Unit
PubMed ID
PubMed Central ID
Embedded videos
Type
Journal article
Language
en
Description
Series/Report no.
ISSN
2395-6429
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
Rights
Attribution 3.0 United States